#44 - Why Europe is missing 100 new drugs: Pierre-Henri Belin’s call for change

Épisode de Pharma Minds par Nathalie Lahitte · 27 octobre 2025 · 57 min

“Europe is missing too many innovations.”

I had the pleasure of welcoming Pierre-Henri Belin, the Co-Founder and CEO of Xcube.Bio — an innovative company that accelerates biopharma market entry across Europe.

By combining capital, deep expertise, and industry knowledge, Xcube.Bio helps mitigate risks and launch transformative solutions.

Pierre-Henri is a leading voice in pharmaceutical innovation and healthcare transformation. In this episode, he shares a bold vision to bridge one of Europe’s most urgent healthcare gaps: the slow access to new drugs for European patients.

In this conversation, we discuss:

◾️ The alarming gap between the United States and Europe — with more than 100 new drugs available in the US but still not accessible to European patients.

◾️ Why this gap exists, from fragmented regulatory systems to national-level decision-making and the lack of early collaboration between key actors.

◾️ The consequences for patients, innovation, and the competitiveness of Europe’s healthcare ecosystem.

◾️ Pierre-Henri’s proposed model, built on transparency, collaboration, and shared responsibility — connecting innovators, regulators, and patients earlier in the process.

◾️ A message of hope, showing that Europe can reinvent its system without sacrificing safety or trust, but only if we act collectively and decisively.

A clear, concrete, and inspiring episode that sheds light on how Europe can regain its leadership in healthcare innovation.

Many thanks to Xcube.Bio for supporting this episode. Their partnership allows us to push our explorations further — but the spirit of Pharma Minds remains unchanged: full editorial independence and complete freedom in choosing our guests.

—

Find Pierre-Henri Belin:

LinkedIn: https://www.linkedin.com/in/phbelin/?originalSubdomain=ch

Xcube.Bio: https://xcube.bio/

Resources mentioned in the episode:

📌 Deloitte Partner: Hanno Ronte

📌 M&A Specialist: Jan Boehler

📌 Former CFO of Big Pharma: Ludo Ooms

📌 Bluebird Bio (now Genetix Biotherapeutics): https://share.google/KHHhGp5HPvr5sDNkE

📌 Agios

Pharma Minds episodes mentioned:

Frédéric Prince on the Bluebird adventure in France (in English): https://smartlink.ausha.co/pharma-minds/frederic-prince-early-development-program-lead-oncology-roche-do-more-was-not-attractive-anymore

—

🎧 New here? To get a quick overview of the episodes, download “25 Tips for Purposeful Leadership”, a guide inspired by the best advice shared by my guests.

🤝 Want to connect or talk about your current challenges? Let’s connect on LinkedIn.

📩 Curious to dive deeper into the major shifts in the healthcare ecosystem? Subscribe to the Pharma Minds newsletter.

Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Autres épisodes de « Pharma Minds »

À propos du podcast

Bienvenue dans Pharma minds, le podcast qui vous emmène dans une aventure captivante à travers la Pharma et la Santé d'aujourd'hui ! Je suis votre hôte, Nathalie Lahitte. Mon objectif ? Découvrir comment des personnalités influentes ont contribué à façonner ce secteur. À chaque épisode, nous…

Pharma Minds

Épisodes similaires

Webinaire / découvrir les ETF avec Amundi : comprendre, choisir et investir – Webinaire
Arrêt maladie, Indemnités limitées à un an : ces enjeux RH que les DRH doivent poser sur la table du CoDir dès maintenant – Capital Humain – Travail, ressources humaines et santé mentale
[AZIMUT ENTREPRENDRE | 1/3] - 15 000 abonnés sans montrer son visage - Safia Hadidi – Donne le Rythme
Bénédicte Henry, sa foi, <br>ses convictions et engagements – Les rencontres du père Jacques Thierry
1000 ads en une semaine : comment Flytex scale ses ads Meta avec l'IA – Le Rendez-vous E-commerce
Le Récap de la semaine - 23/10/2026 – Matthias Baccino

Tous les épisodes de Pharma Minds · Plus de podcasts Business